Fentanyl Citrate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Fentanyl Citrate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Dec 20, 2023. Reported reason: Other

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6026-05
Dosage Form
Injection
Presentation
Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05)
Initial Posting
Dec 20, 2023

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.